Global RNA Targeted Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Type of Target Molecule (Cap Binding Complex, CDKL5, Dystrophin Protein, G542X, MNK1/MNK2, PAX6 gene, and SMN2), By Type of Approach (Indirect RNA Targeting, mRNA Translation Modulation, and RNA Splicing Modification), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Jun 2025
REPORT ID SI12461
PAGES 233
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type of Target Molecule
      2. Market Attractiveness Analysis By Type of Approach
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising clinical trial successes
    3. Restraints
      1.  Delivery & stability issues
    4. Opportunities
      1. RNA interference (RNAi) and antisense technologies
    5. Challenges
      1. Manufacturing and Scalability
  6. Global RNA Targeted Therapeutics Market Analysis and Projection, By Type of Target Molecule
    1. Segment Overview
    2. Cap Binding Complex
    3. CDKL5
    4. Dystrophin Protein
    5. G542X
    6. MNK1/MNK2
    7. PAX6 gene
    8. SMN2
  7. Global RNA Targeted Therapeutics Market Analysis and Projection, By Type of Approach
    1. Segment Overview
    2. Indirect RNA Targeting
    3. mRNA Translation Modulation
    4. RNA Splicing Modification
  8. Global RNA Targeted Therapeutics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global RNA Targeted Therapeutics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the RNA Targeted Therapeutics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Abivax
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   AC Immune 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Arrakis Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   eFFECTOR Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Eloxx Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  H3 Biomedicine
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   PTC Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Ribometrix
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Skyhawk Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  STORM Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  2. Global Cap Binding Complex, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  3. Global CDKL5, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  4. Global Dystrophin Protein, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  5. Global G542X, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  6. Global MNK1/MNK2, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  7. Global RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  8. Global Indirect RNA Targeting, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  9. Global mRNA Translation Modulation, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  10. Global RNA Splicing Modification, RNA Targeted Therapeutics Market, By Region, 2024-2035(USD Billion)
  11. North America RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  12. North America RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  13. U.S.  RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  14. U.S.  RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  15. Canada RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  16. Canada RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  17. Mexico RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  18. Mexico RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  19. Europe RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  20. Europe RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  21. Germany RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  22. Germany RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  23. France RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  24. France RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  25. U.K.  RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  26. U.K.  RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  27. Italy RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  28. Italy RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  29. Spain RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  30. Spain RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  31. Asia Pacific RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  32. Asia Pacific RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  33. Japan RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  34. Japan RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  35. China RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  36. China RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  37. India RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  38. India RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  39. South America RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  40. South America RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  41. Brazil RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  42. Brazil RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  43. The Middle East and Africa RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD   Billion)
  44. The Middle East and Africa RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD   Billion)
  45. UAE RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  46. UAE RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)
  47. South Africa RNA Targeted Therapeutics Market, By Type of Target Molecule, 2024-2035(USD Billion)
  48. South Africa RNA Targeted Therapeutics Market, By Type of Approach, 2024-2035(USD Billion)

List of Figures 

  1. Global RNA Targeted Therapeutics Market Segmentation
  2. RNA Targeted Therapeutics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the RNA Targeted Therapeutics Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  RNA Targeted Therapeutics Market
  20. RNA Targeted Therapeutics Market Segmentation, By Type of Target Molecule
  21. RNA Targeted Therapeutics Market For Cap Binding Complex, By Region, 2024-2035 ($ Billion)
  22.  RNA Targeted Therapeutics Market For CDKL5, By Region, 2024-2035 ($ Billion)
  23. RNA Targeted Therapeutics Market For Dystrophin Protein, By Region, 2024-2035 ($ Billion)
  24. RNA Targeted Therapeutics Market For G542X, By Region, 2024-2035 ($ Billion)
  25. RNA Targeted Therapeutics Market For MNK1/MNK2, By Region, 2024-2035 ($ Billion)
  26.  RNA Targeted Therapeutics Market Segmentation, By Type of Approach
  27.  RNA Targeted Therapeutics Market For Indirect RNA Targeting, By Region, 2024-2035 ($ Billion)
  28.  RNA Targeted Therapeutics Market For mRNA Translation Modulation, By Region, 2024-2035 ($ Billion)
  29. RNA Targeted Therapeutics Market For RNA Splicing Modification, By Region, 2024-2035 ($ Billion)
  30. Abivax: Net Sales, 2024-2035 ($ Billion)
  31. Abivax: Revenue Share, By Segment, 2024 (%)
  32. Abivax: Revenue Share, By Region, 2024 (%)
  33. AC Immune: Net Sales, 2024-2035 ($ Billion)
  34. AC Immune: Revenue Share, By Segment, 2024 (%)
  35. AC Immune: Revenue Share, By Region, 2024 (%)
  36. Arrakis Therapeutics: Net Sales, 2024-2035 ($ Billion)
  37. Arrakis Therapeutics: Revenue Share, By Segment, 2024 (%)
  38. Arrakis Therapeutics: Revenue Share, By Region, 2024 (%)
  39. eFFECTOR Therapeutics: Net Sales, 2024-2035 ($ Billion)
  40. eFFECTOR Therapeutics: Revenue Share, By Segment, 2024 (%)
  41. eFFECTOR Therapeutics: Revenue Share, By Region, 2024 (%)
  42. Eloxx Pharmaceuticals: Net Sales, 2024-2035 ($ Billion)
  43. Eloxx Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  44. Eloxx Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  45. H3 Biomedicine: Net Sales, 2024-2035 ($ Billion)
  46. H3 Biomedicine: Revenue Share, By Segment, 2024 (%)
  47. H3 Biomedicine: Revenue Share, By Region, 2024 (%)
  48. PTC Therapeutics: Net Sales, 2024-2035 ($ Billion)
  49. PTC Therapeutics: Revenue Share, By Segment, 2024 (%)
  50. PTC Therapeutics: Revenue Share, By Region, 2024 (%)
  51. Ribometrix: Net Sales, 2024-2035 ($ Billion)
  52. Ribometrix: Revenue Share, By Segment, 2024 (%)
  53. Ribometrix: Revenue Share, By Region, 2024 (%)
  54. Skyhawk Therapeutics.: Net Sales, 2024-2035 ($ Billion)
  55. Skyhawk Therapeutics.: Revenue Share, By Segment, 2024 (%)
  56. Skyhawk Therapeutics.: Revenue Share, By Region, 2024 (%)
  57. STORM Therapeutics: Net Sales, 2024-2035 ($ Billion)
  58. STORM Therapeutics: Revenue Share, By Segment, 2024 (%)
  59. STORM Therapeutics: Revenue Share, By Region, 2024 (%)
  60. Others: Net Sales, 2024-2035 ($ Billion)
  61. Others: Revenue Share, By Segment, 2024 (%)
  62. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:102
Pages:233
Countries covered:20
Companies covered::15
Forecast CAGR:CAGR Of 35.23%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies